It is not possible to see whether these events are related straightaway to the utilise of PDE5 inhibitors or to early factors [see ADVERSE REACTIONS]. Physicians should counsel patients to stop over exercise of totally phosphodiesterase typewrite 5 (PDE5) inhibitors, …
